Iodide

Iodide

SCHEMBL1804181

C[n+]1ccc(/C=C/c2ccc3cc(O)ccc3c2)cc1.[I-]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.47
ALDH1A1 P00352 3/20 0.68
MAPT P10636 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
GLA P06280 1/20 0.68
KDM4E B2RXH2 2/20 0.51
RAB9A P51151 2/20 0.51
HPGD P15428 1/20 0.51
CYP2C19 P33261 1/20 0.51
CHAT P28329 4/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 1/20 0.49
LMNA P02545 1/20 0.49
ALPG P10696 1/20 0.49
THRB P10828 1/20 0.49
HTT P42858 1/20 0.49
GFER P55789 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
POLB P06746 2/20 0.47
PTGS1 P23219 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL1804188 1.00 ALDH1A1 (0.68) ALDH1A1MAPTSMN1; SMN2GLAKDM4E
SCHEMBL13964870 0.98 ALDH1A1 (0.70) ALDH1A1MAPTSMN1; SMN2GLAKDM4E
SCHEMBL18383563 0.88 ALDH1A1 (0.85) ALDH1A1MAPTSMN1; SMN2GLAKDM4E
SCHEMBL18383564 0.84 ALDH1A1 (0.79) ALDH1A1MAPTSMN1; SMN2GLAKDM4E
Iodide SCHEMBL31042224 0.84 ALDH1A1 (0.64) ALDH1A1MAPTSMN1; SMN2GLAKDM4E
Iodide SCHEMBL1804717 0.83 ALDH1A1 (0.96) ALDH1A1MAPTSMN1; SMN2GLAKDM4E
Iodide SCHEMBL1804720 0.83 ALDH1A1 (0.96) ALDH1A1MAPTSMN1; SMN2GLAKDM4E
SCHEMBL9770819 0.82 CHAT (0.61) ALDH1A1MAPTSMN1; SMN2GLAKDM4E
SCHEMBL12125135 0.82 CHAT (0.61) ALDH1A1MAPTSMN1; SMN2GLAKDM4E
SCHEMBL13615223 0.79 ALDH1A1 (0.72) ALDH1A1MAPTSMN1; SMN2GLAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120294808-A1 Fluorescent Analogs of Neurotransmitters, Compositions Containing the Same and Methods of Using the Same UNIVERSITY OF MIAMI (US) 2012-11-22 US disclosed
WO-2011057229-A2 FLUORESCENT ANALOGS OF NEUROTRANSMITTERS, COMPOSITIONS CONTAINING THE SAME AND METHODS OF USING THE SAME UNIVERSITY OF MIAMI (US) 2011-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120294808-A1 Fluorescent Analogs of Neurotransmitters, Compositions Containing the Same and Methods of Using the Same HRH3, CHRNA4, HRH4 ACHE 1250/4885ALDH1A1 1735/4885MAPT 2027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.